Netscientific PLC
NSCI.UK
$0.79
Closing
0.00
1D
▲5.00%
YTD
Market cap
$18.80M
52 week high
$1.03
52 week low
$0.60
Volume
1,654
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$18.80M
Analysts' Rating
-
Price Target (Mean)
2.293046459
Total Analysts
0
P/E
Operating Margin
-209.61%
Beta
2.05
Revenue Growth (Annual)
-18.46%
52 week high
$1.03
52 week low
$0.60
Div. Yield
%
EPS Annual Growth
0.00
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
NetScientific Plc is a United Kingdom-based investment and commercialization company with an international portfolio of life science, sustainability, and technology companies. The Company identifies, invests in, and builds companies in the United Kingdom and internationally. It develops investment strategies for its subsidiaries and portfolio companies. Its portfolio consists of a combination of direct investments and capital under advisory. It has developed a customized investment and realization strategy for its portfolio companies through management, incubation, advisory services, and fund-raising support. It facilitates the companies it works with, to access the type of funding, management support and resources specific to their sector, stage of development and available opportunities. The Company’s subsidiaries include EMV Capital Limited, Glycotest, Inc. and ProAxsis Limited, among others.
